Evaluation and Management of Liver Masses - Division of Gastroenterology and Hepatology Mayo Clinic Rochester, MN USA | Springer Nature Switzerland AG | 2020

This text provides a comprehensive and state-of-the-art overview of the evaluation and management of liver mass lesions. Major topics covered include epidemiology, the use of different imaging modalities in the differential diagnosis of liver lesions, the use of biomarkers and immunohistochemical stains for diagnosis, and treatment of the different types of liver masses. These include hepatocellular adenoma and hepatocellular carcinoma, fibrolamellar carcinoma, cholangiocarcinoma, hemangioma, focal nodular hyperplasia, liver masses in adult patients with congenital heart disease, and other infectious, inflammatory, and cystic lesions of the liver. The volume presents highly practical case presentations of typical patients seen in a clinical hepatobiliary practice.

Written by experts from multiple disciplines, Evaluation and Management of Liver Masses is a valuable resource for clinicians and professionals who manage patients with these conditions.

ISBN: 978-3-030-46698-5 978-3-030-46699-2 (eBook) = a b abdominal ablation abscesses adjuvant AJR angiosarcoma Ann Surg arterial phase background liver benign bile duct biliary tract cancers biopsy calcifications capecitabine CCA cells central scar cHCC-CCA chemotherapy cholangiocarcinoma cirrhosis computed tomography congestion contrast agent contrast-enhanced CT cystic cysts demonstrates diagnosis differentiation diffuse echogenic enhancement evaluation fibrosis Fig FLC FNH focal nodular hyperplasia G gallbladder cancer Gastroenterol GBC gemcitabine HCA HCC hemangioma hemorrhage hepatic adenoma hepatoblastoma hepatocellular adenoma hepatocellular carcinoma hepatocytes Hepatol Hepatology heterogeneous histologic hyperenhancement hyperintense hypoattenuating hypoechoic iCCA imaging features imaging findings infection inflammatory intrahepatic cholangiocarcinoma Kim lesions liver disease liver transplantation lymph node lymphoma malignant mass Mayo Clinic metastases MRI necrosis nodules outcomes oxaliplatin Pathol Pathology patients percutaneous peripheral portal vein portal venous phase Primary hepatic Radiol Radiology radiotherapy risk Roentgenol shows signal sorafenib subtype Surg Oncol surgical resection survival T2-weighted therapy tomography transarterial treatment tumor typically ultrasound unresectable USA e-mail vascular washout white arrow

Subjects--Personal Names: --Gastroenterology, Internal medicine, Medical / Clinical Medicine, Medical / Gastroenterology, Medical / Hepatology, Electronic books, Hepatology, Liver -- Cancer -- Diagnosis -- Tumors -- Treatment.